Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccae to Prevent Tuberculosis in High Risk Groups
NCT01979900Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- Oct 2013
- Primary completion
- Nov 2017
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Mycobacterium vaccae vaccine in Tuberculosis (TB), sponsored by Zhifei Biological. Started Oct 2013; status: completed.
02
Drugs
Mycobacterium vaccae vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01979900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01979900.